Since its inception, HIPRA has supported veterinarians, farmers and pet owners in disease prevention through the development of innovative vaccines, vaccination devices, diagnostic services and advanced data analysis.
With over 50 years of experience in researching, producing, and marketing animal health vaccines, HIPRA has positioned itself as the fifth-largest veterinary product company worldwide.
For HIPRA, prevention is the best alternative to antibiotic usage in animals, enhancing the quality of animal protein consumed by humans and reducing antimicrobial resistance. This vision aligns with the strategy of the One Health global initiative, which advocates for the health of people, animals and the environment.